3 citations
,
January 2022 in “Scientific Reports” This study found that SAMiRNA-AR68, a nanomedicine targeting androgen receptor mRNA, increased hair counts in androgenetic alopecia patients with no observed side effects.
November 2024 in “EMJ Dermatology” In clinical studies, inhibiting androgen receptor expression using CosmeRNA ARI SAMiRNA micelles effectively treated androgenetic alopecia by significantly increasing hair growth, as reported in this research.
December 2025 in “Journal of the European Academy of Dermatology and Venereology” This source states that an image was mistakenly misused in the supplementary materials but clarifies that this does not impact the study's main findings. The authors have corrected the error for accuracy and transparency.
January 2026 in “Annals of Medicine and Surgery” This article corrects an author name in a previously published study on the application of retinoids for androgenic alopecia, without presenting new research findings.